Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, Q2 2026
-8.45
Period ended Jun 30, 2026
Change on a year earlier
-641.7%
1.56 in Q2 2025
History
65 quarters
Since Q2 2008
Sources
55
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diluted earnings (loss) per share ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -8.45 | -641.7% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 1.61 | +54.8% | Form 10-Q (filed 2026-05-07) ↗ |
| Q3 2025 | Sep 30, 2025 | 2.43 | +143.0% | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 1.56 | +20.9% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 1.04 | -131.1% | Form 10-Q (filed 2025-05-07) ↗ |
| Q3 2024 | Sep 30, 2024 | 1 | -42.2% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 1.29 | +55.4% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | -3.34 | -517.5% | Form 10-Q (filed 2024-05-08) ↗ |
| Q3 2023 | Sep 30, 2023 | 1.73 | +21.8% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 0.83 | -8.8% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 0.80 | +3,900.0% | Form 10-Q (filed 2023-05-03) ↗ |
| Q3 2022 | Sep 30, 2022 | 1.42 | -30.7% | Form 10-Q (filed 2022-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 0.91 | -24.8% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 0.02 | -98.5% | Form 10-Q (filed 2022-05-04) ↗ |
| Q3 2021 | Sep 30, 2021 | 2.05 | +606.9% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 1.21 | -145.5% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 1.37 | +12.3% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 1.23 | -42.0% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 0.29 | -131.5% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | -2.66 | -281.0% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 1.22 | -20.8% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 2.12 | – | Form 10-K (filed 2020-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | -0.92 | -157.5% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 1.47 | +5.8% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1.54 | +31.6% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 0 | -100.0% | Form 10-K (filed 2019-02-26) ↗ |
| Q3 2018 | Sep 30, 2018 | 1.60 | -22.3% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 1.39 | -40.3% | Form 10-Q (filed 2018-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 1.17 | -42.9% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | -2.96 | -226.5% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 2.06 | -17.3% | Form 10-Q (filed 2017-11-07) ↗ |
| Q2 2017 | Jun 30, 2017 | 2.33 | -9.7% | Form 10-Q (filed 2017-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 2.05 | -19.0% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 2.34 | -26.4% | Form 10-K (filed 2017-02-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 2.49 | -18.6% | Form 10-Q (filed 2016-11-07) ↗ |
| Q2 2016 | Jun 30, 2016 | 2.58 | -11.6% | Form 10-Q (filed 2016-08-05) ↗ |
| Q1 2016 | Mar 31, 2016 | 2.53 | -8.3% | Form 10-Q (filed 2016-05-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 3.18 | +45.9% | Form 10-K (filed 2016-02-24) ↗ |
| Q3 2015 | Sep 30, 2015 | 3.06 | +83.2% | Form 10-Q (filed 2015-11-04) ↗ |
| Q2 2015 | Jun 30, 2015 | 2.92 | +32.7% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 2.76 | +107.5% | Form 10-Q (filed 2015-05-08) ↗ |
| Q4 2014 | Dec 31, 2014 | 2.18 | +363.8% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2014 | Sep 30, 2014 | 1.67 | +255.3% | SEC Filing ↗ |
| Q2 2014 | Jun 30, 2014 | 2.20 | +378.3% | SEC Filing ↗ |
| Q1 2014 | Mar 31, 2014 | 1.33 | +209.3% | SEC Filing ↗ |
| Q4 2013 | Dec 31, 2013 | 0.47 | 0.0% | Form 10-K (filed 2014-02-25) ↗ |
| Q3 2013 | Sep 30, 2013 | 0.47 | +9.3% | Form 10-Q (filed 2013-10-31) ↗ |
| Q2 2013 | Jun 30, 2013 | 0.46 | 0.0% | Form 10-Q (filed 2013-08-01) ↗ |
| Q1 2013 | Mar 31, 2013 | 0.43 | +53.6% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 0.47 | +9.3% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 0.43 | -8.5% | Form 10-K (filed 2013-02-27) ↗ |
| Q2 2012 | Jun 30, 2012 | 0.46 | -2.1% | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2012 | Mar 31, 2012 | 0.28 | -30.0% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 0.43 | +13.2% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2011 | Sep 30, 2011 | 0.47 | – | Form 10-K (filed 2013-02-27) ↗ |
| Q2 2011 | Jun 30, 2011 | 0.47 | – | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2011 | Mar 31, 2011 | 0.40 | -13.0% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2010 | Dec 31, 2010 | 0.38 | -11.6% | Form 10-K (filed 2011-02-28) ↗ |
| Q1 2010 | Mar 31, 2010 | 0.46 | +43.8% | Form 10-Q (filed 2010-05-10) ↗ |
| Q4 2009 | Dec 31, 2009 | 0.43 | – | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 0.36 | +38.5% | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2009 | Jun 30, 2009 | 0.30 | +30.4% | Form 10-Q (filed 2009-08-05) ↗ |
| Q1 2009 | Mar 31, 2009 | 0.32 | – | Form 10-Q (filed 2010-05-10) ↗ |
| Q3 2008 | Sep 30, 2008 | 0.26 | – | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2008 | Jun 30, 2008 | 0.23 | – | Form 10-Q (filed 2009-08-05) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Diluted earnings (loss) per share ($/sh) ($), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_eps_dil
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.